Catalyst Event
Hangzhou Tigermed Consulting Co Ltd (3347) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
5/13/2026, 12:00:00 AM
Announced a share repurchase plan for A-shares with a total amount of RMB 500 million to RMB 1 billion, at a price not exceeding RMB 60.00 per share, announced on May 13, 2026. The shares will be used for employee incentives or cancellation. This large-scale buyback is estimated to have a price impact of ≥5%.
Korean Translation
2026년 5월 13일, 총 5억~10억 위안 규모의 A주 자사주 매입 계획을 발표함. 매입 가격은 주당 60.00위안을 초과하지 않으며, 매입된 주식은 직원 인센티브 또는 소각에 사용될 예정임. 이는 5% 이상의 주가 상승을 견인할 것으로 예상됨.
Related Recent Events
3SBio Inc (1530) · Earnings Release
First half 2026 earnings results are expected to be released around August 26, 2026, expected. High importance is estimated due to the significant impact of previous earnings growth on stock volatility.
8/26/2026, 12:00:00 AM
Cochlear Ltd (COH) · Earnings Release
Cochlear's full-year financial results for fiscal year 2026 are scheduled to be announced on August 18, 2026. Medium importance is estimated as annual earnings reports typically result in price movements exceeding 5%, scheduled.
8/18/2026, 12:00:00 AM
3SBio Inc (1530) · Other
The ex-dividend date for the final cash dividend of HKD 0.25 per share for the fiscal year 2025 is July 21, 2026, scheduled.
7/21/2026, 12:00:00 AM
Sino Biopharmaceutical Ltd (1177) · Other
The ex-dividend date for the proposed final dividend of HKD 0.05 per share is 2026-06-24, which is estimated to have a price impact of ≥1% scheduled.
6/24/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic to report Q4 and full fiscal year 2026 financial results, scheduled.
6/3/2026, 12:00:00 AM